Publikationen von H. Eibl

Koetting, J.; Berger, M. R.; Unger, C.; Eibl, H.: Alkylphosphocholines: Influence of structural variation on biodistribution at antineoplastically active concentrations. Cancer Chemotherapy and Pharmacology 30 (2), S. 105 - 112 (1992)

Ries, U.; Fleer, E. A. M.; Eibl, H.: Synthesis of alkylphosphonates, a new class of antineoplastic agents. Chemistry and Physics of Lipids 61 (3), S. 225 - 234 (1992)

Hochhuth, C.; Vehmeyer, K.; Eibl, H.; Unger, C.: Hexadecylphosphocholine induces interferon-γ secretion and expression of GM-CSF mRNA in human mononuclear cells. Cellular Immunology 141 (1), S. 161 - 168 (1992)

Berger, M. R.; Yanapirut, P.; Reinhardt, M.; Klenner, T.; Scherf, H. R.; Schmeiser, H. H.; Eibl, H.: Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas. Progress in Experimental Tumor Research 34, S. 98 - 115 (1992)

Berkovic, D.; Fleer, E. A. M.; Eibl, H.; Unger, C.: Effects of hexadecylphosphocholine on cellular function. Progress in Experimental Tumor Research 34, S. 59 - 68 (1992)

Eibl, H.; Engel, J.: Synthesis of hexadecylphosphocholine (miltefosine). Progress in Experimental Tumor Research 34, S. 1 - 5 (1992)

Filthuth, E.; Eibl, H.: Synthesis of enantiomerically pure lysophosphatidylinositols and alkylphosphoinositols. Chemistry and Physics of Lipids 60 (3), S. 253 - 261 (1992)

Fleer, E. A. M.; Berkovic, D.; Unger, C.; Eibl, H.: Cellular uptake and metabolic fate of hexadecylphosphocholine. Progress in Experimental Tumor Research 34, S. 33 - 46 (1992)

Hochhuth, C.; Doenecke, D.; Unger, C.; Eibl, H.: Early effects of hexadecylphosphocholine on gene expression in leukemia cell lines. Progress in Experimental Tumor Research 34, S. 77 - 89 (1992)

Kaufmann-Kolle, P.; Unger, C.; Eibl, H.: Hexadecylphosphocholine in liposomal dispersions. Progress in Experimental Tumor Research 34, S. 12 - 24 (1992)

Koetting, J.; Marschner, N.; Neumueller, W.; Unger, C.; Eibl, H.: Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution. Progress in Experimental Tumor Research 34, S. 131 - 142 (1992)

Koetting, J.; Marschner, N.; Unger, C.; Eibl, H.: Determination of alkylphosphocholines and of alkyl-glycero-phosphocholines in biological fluids and tissues. Progress in Experimental Tumor Research 34, S. 6 - 11 (1992)

Reitz, R. C.; Koetting, J.; Unger, C.; Eibl, H.: Comparison of the tissue distribution of hexadecylphosphocholine and erucylphosphocholine. Progress in Experimental Tumor Research 34, S. 143 - 152 (1992)

Unger, C.; Fleer, E. A. M.; Koetting, J.; Neumueller, W.; Eibl, H.: Antitumoral activity of alkylphosphocholines and analogues in human leukemia cell lines. Progress in Experimental Tumor Research 34, S. 25 - 32 (1992)

Unger, C.; Peukert, M.; Sindermann, H.; Hilgard, P.; Nagel, G.; Eibl, H.: Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Progress in Experimental Tumor Research 34 (2-3), S. 153 - 159 (1992)

Unger, C.; Sindermann, H.; Peukert, M.; Hilgard, P.; Engel, J.; Eibl, H.: Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Progress in Experimental Tumor Research 34, S. 153 - 159 (1992)

Vehmeyer, K.; Eibl, H.; Unger, C.: Hexadecylphosphocholine stimulates the colony-stimulating factor-dependent growth of hemopoietic progenitor cells. Experimental Hematology 20 (1), S. 1 - 5 (1992)

Vehmeyer, K.; Liersch, T.; Eibl, H.; Unger, C.: Hexadecylphosphocholine amplifies the effect of granulocyte colony-stimulating factor on differentiating hematopoietic progenitor cells. Progress in Experimental Tumor Research 34, S. 69 - 76 (1992)

Vogler, W. R.; Olson, A. C.; Okamoto, S.; Shoji, M.; Raynor, R. L.; Kuo, J. F.; Berdel, W. E.; Eibl, H.; Hajdu, J.; Nomura, H.: Comparison of selective cytotoxicity of alkyl lysophospholipids. Lipids 26 (12), S. 1418 - 1423 (1991)

Jain, M. K.; Tao, W. J.; Rogers, J.; Arenson, C.; Eibl, H.; Yu, B. Z.: Active-site-directed specific competitive inhibitors of phospholipase A2: novel transition-state analogs. Biochemistry 30 (42), S. 10256 - 10268 (1991)